Tubo-Ovarian Transitional Cell Carcinoma and High-grade Serous Carcinoma Show Subtly Different Immunohistochemistry Profiles

Jamie Magrill, Anthony N. Karnezis, Basile Tessier-Cloutier, Aline Talhouk, Stefan Kommoss, Dawn Cochrane, Christine Chow, Angela Cheng, Robert Soslow, Steffen Hauptmann, Andreas du Bois, Jacobus Pfisterer, C. Blake Gilks, David G. Huntsman, Friedrich Kommoss*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)552-561
Number of pages10
JournalInternational Journal of Gynecological Pathology
Volume38
Issue number6
DOIs
Publication statusPublished - Nov 2019

Keywords

  • Ovarian cancer
  • Transitional cell carcinoma
  • High-grade serous carcinoma
  • Immunohistochemistry
  • Biomarkers
  • OVARIAN-CARCINOMA
  • UROTHELIAL DIFFERENTIATION
  • PROSTATE ADENOCARCINOMA
  • INVASION PATTERNS
  • BRCA2 MUTATIONS
  • BRENNER-TUMORS
  • USEFUL MARKER
  • T-CELLS
  • EXPRESSION
  • SURVIVAL

Cite this

Magrill, J., Karnezis, A. N., Tessier-Cloutier, B., Talhouk, A., Kommoss, S., Cochrane, D., Chow, C., Cheng, A., Soslow, R., Hauptmann, S., du Bois, A., Pfisterer, J., Gilks, C. B., Huntsman, D. G., & Kommoss, F. (2019). Tubo-Ovarian Transitional Cell Carcinoma and High-grade Serous Carcinoma Show Subtly Different Immunohistochemistry Profiles. International Journal of Gynecological Pathology, 38(6), 552-561. https://doi.org/10.1097/PGP.0000000000000538